JP2014533290A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533290A5 JP2014533290A5 JP2014541423A JP2014541423A JP2014533290A5 JP 2014533290 A5 JP2014533290 A5 JP 2014533290A5 JP 2014541423 A JP2014541423 A JP 2014541423A JP 2014541423 A JP2014541423 A JP 2014541423A JP 2014533290 A5 JP2014533290 A5 JP 2014533290A5
- Authority
- JP
- Japan
- Prior art keywords
- env polypeptide
- immunogenic composition
- item
- polypeptide
- polyanionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559512P | 2011-11-14 | 2011-11-14 | |
| US61/559,512 | 2011-11-14 | ||
| PCT/US2012/065113 WO2013074696A1 (en) | 2011-11-14 | 2012-11-14 | Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014533290A JP2014533290A (ja) | 2014-12-11 |
| JP2014533290A5 true JP2014533290A5 (https=) | 2016-01-07 |
Family
ID=47222339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541423A Pending JP2014533290A (ja) | 2011-11-14 | 2012-11-14 | ポリアニオン性カルボマーとＥｎｖポリペプチドとの免疫原性複合体ならびにその製造法および使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9393300B2 (https=) |
| EP (1) | EP2780035A1 (https=) |
| JP (1) | JP2014533290A (https=) |
| CN (1) | CN104271155A (https=) |
| AU (1) | AU2012340035A1 (https=) |
| BR (1) | BR112014011560A2 (https=) |
| CA (1) | CA2855826A1 (https=) |
| MX (1) | MX2014005548A (https=) |
| RU (1) | RU2014124154A (https=) |
| WO (1) | WO2013074696A1 (https=) |
| ZA (1) | ZA201402910B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2625189B1 (en) | 2010-10-01 | 2018-06-27 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| DE19216461T1 (de) | 2011-10-03 | 2021-10-07 | Modernatx, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
| CA3018046A1 (en) | 2011-12-16 | 2013-06-20 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| EP3052521A1 (en) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US3790665A (en) | 1968-02-23 | 1974-02-05 | Haver Lockhart Labor Inc | Injectable adjuvant,method of preparing same and compositions including such adjuvant |
| US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
| US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| JPH0832637B2 (ja) * | 1985-02-14 | 1996-03-29 | アクゾ・エヌ・ヴエー | 合成免疫原 |
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| ATE112687T1 (de) | 1988-09-13 | 1994-10-15 | Chiron Corp | Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5840313A (en) | 1990-09-27 | 1998-11-24 | Syntello Vaccine Development Kb | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| EP0688205A1 (en) * | 1993-03-11 | 1995-12-27 | Secretech, Inc. | Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| CN1111540C (zh) | 1993-06-09 | 2003-06-18 | 康诺特实验室有限公司 | 串联的合成hiv－1肽类 |
| US5741492A (en) | 1996-01-23 | 1998-04-21 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| AU2221600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
| JP4776075B2 (ja) | 1998-12-31 | 2011-09-21 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 改変ｈｉｖｅｎｖポリペプチド |
| JP2006509039A (ja) * | 2002-12-03 | 2006-03-16 | ユニバーシティ オブ マサチューセッツ | 多価初代ｈｉｖ−１糖タンパク質ｄｎａワクチンおよびワクチン接種方法 |
| AU2006304725B2 (en) * | 2005-10-17 | 2012-03-15 | Novartis Ag | Multiclade HIV vaccines |
| JP2009536653A (ja) * | 2006-05-09 | 2009-10-15 | ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | Ｈｉｖ−１免疫原性組成物 |
| WO2011003138A1 (en) * | 2009-07-06 | 2011-01-13 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
-
2012
- 2012-11-14 CN CN201280055731.5A patent/CN104271155A/zh active Pending
- 2012-11-14 BR BR112014011560A patent/BR112014011560A2/pt not_active IP Right Cessation
- 2012-11-14 WO PCT/US2012/065113 patent/WO2013074696A1/en not_active Ceased
- 2012-11-14 JP JP2014541423A patent/JP2014533290A/ja active Pending
- 2012-11-14 MX MX2014005548A patent/MX2014005548A/es unknown
- 2012-11-14 AU AU2012340035A patent/AU2012340035A1/en not_active Abandoned
- 2012-11-14 RU RU2014124154/15A patent/RU2014124154A/ru not_active Application Discontinuation
- 2012-11-14 US US14/357,270 patent/US9393300B2/en not_active Expired - Fee Related
- 2012-11-14 CA CA2855826A patent/CA2855826A1/en not_active Abandoned
- 2012-11-14 EP EP12791061.0A patent/EP2780035A1/en not_active Withdrawn
-
2014
- 2014-04-22 ZA ZA2014/02910A patent/ZA201402910B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533290A5 (https=) | ||
| CA2972753C (en) | Swarm immunization with envelopes from ch505 | |
| Iyer et al. | Virus-like particles displaying trimeric simian immunodeficiency virus (SIV) envelope gp160 enhance the breadth of DNA/modified vaccinia virus Ankara SIV vaccine-induced antibody responses in rhesus macaques | |
| RU2014124154A (ru) | Иммуногенные комплексы полианионных карбомеров и полипептидов env и способы их получения и применения | |
| US11897919B2 (en) | Multivalent HIV vaccine boost compositions and methods of use | |
| US8916174B2 (en) | HIV DNA vaccine regulated by a caev-derived promoter | |
| US10322141B2 (en) | Compositions comprising CH848 envelopes and uses thereof | |
| US8765140B2 (en) | DNA vaccine compositions with HIV/SIV gene modifications | |
| US10232034B2 (en) | Compositions comprising CH505 envelopes, and trimers | |
| Bazhan et al. | A synergistic effect of a combined bivalent DNA–protein anti-HIV-1 vaccine containing multiple T-and B-cell epitopes of HIV-1 proteins | |
| US20180036400A1 (en) | Double engineered hiv-1 envelopes | |
| US20170107260A1 (en) | Mosaic hiv-1 sequences and uses thereof | |
| CA2983259A1 (en) | Swarm immunization with envelopes from ch505 | |
| WO2017152144A1 (en) | Swarm immunization with envelopes from ch505 | |
| Hallengärd | Strategies to enhance the potency of HIV-1 DNA vaccines | |
| Kochhar et al. | Advancement in AIDS vaccine development | |
| MXPA06002993A (en) | Dna vaccine compositions and methods of use |